A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.

References

• Rohdenburg GL, Bernhard A, Krehbiel O: Sugar tolerance in cancer. JAMA 72: 1528–1534, 1919.
   Google Scholar
• Heber D, Byerley LO, Chlebowski RT: Metabolic abnormalities in the cancer patient. Cancer 55: 225–229, 1985.
   PubMedGoogle Scholar
• Chlebowski RT, Heber D, Richardson B, Block JB: Influence of hydrazine sulfate on abnormal carbohydrate metabolism in cancer patients with weight loss. Cancer Res 44: 857–861, 1984.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Bergman RN: Insulin insensitivity in localized head and neck cancer patients. Clin Res 37: 462A, 1989.
   Google Scholar
• Lundholm K, Holm G, Schersten T: Insulin resistance in patients with cancer. Cancer 38: 4665–4670, 1978.
   Google Scholar
• Marks PA, Bishop JS: The glucose metabolism of patients with malignant disease and of normal subjects as studied by means of intravenous glucose tolerance test. J Clin Invest 36: 254–264, 1957.
   PubMed Web of Science ®Google Scholar
• Holroyde CP, Skutches CL, Boden G, Reichard PR: Glucose metabolism in cachectic patients with colorectal cancer. Cancer Res 44: 5910–5913, 1984.
   PubMed Web of Science ®Google Scholar
• Glicksman AS, Rawson RW: Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 9: 1127–1134, 1956.
   PubMed Web of Science ®Google Scholar
• Norton JA, Maher M, Wesley R, White D, Brennan MF: Glucose intolerance in sarcoma patients. Cancer 54: 3022- 3027, 1984.
   PubMed Web of Science ®Google Scholar
• Heber D, Chlebowski RT, Ishibashi DE, Herrold JN, Block JB: Abnormalities in glucose and protein metabolism in non-cachectic lung cancer patients. Cancer Res 42: 4815–4819, 1982.
   PubMed Web of Science ®Google Scholar
• Jasani B, Donaldson LJ, Ratcliffe JG, Sokhi GS: Mechanism of impaired glucose tolerance in patients with neoplasia. Br J Cancer 38: 287–292, 1978.
   PubMed Web of Science ®Google Scholar
• Rao RH: Diabetes in the undernourished: Coincidence or consequence? Endocr Rev 9(l):67–87, 1988.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Bergner EA, Lee WP: Correction of glucose carbon recycling for the determination of “true” hepatic glucose production (HGP) rates by 1–13C-glucose. Biological Mass Spectrum 20 (4):186–190, 1991.
   PubMedGoogle Scholar
• Butler PC, Kryshad J, Schwenk WF, Haymond MW, Rizza RA: Hepatic and extrahepatic responses to insulin in NIDDM and nondiabetic humans. Diabetes 39: 217–225, 1990.
   PubMedGoogle Scholar
• Campbell PJ, Mandarino LJ, Gerich JE: Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripherial glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest 37: 15–21, 1988.
   Google Scholar
• Holroyde CP, Gabuzda TG, Putnam RC, Paul P, Reichard GA: Altered glucose metabolism in metastatic carcinoma. Cancer Res 35: 3710–3714, 1975.
   PubMed Web of Science ®Google Scholar
• Lundholm K, Edstrom S, Karlberg I, Ekman L, Schersten T: Glucose turnover, gluconeogenesis from glycerol, and estimation of net glucose cycling in cancer patients. Cancer 50: 1142–1150, 1982.
   PubMed Web of Science ®Google Scholar
• Shaw JHF, Wolfe RR: Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer. Surgery 101: 181–191, 1987.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Bulcavage L, Chlebowski RT: Relationship of hepatic glucose production (HGP) to growth hormone levels and malnutrition in a population with colorectal carcinoma. Cancer Res 50: 2119–2122, 1990.
   PubMedGoogle Scholar
• Castillo M, Scheen A, Lefebvre PJ, Luyckx AS: Insulin-stimulated glucose disposal is not increased in anorexia nervosa. J Clin Endocrinol Metab 60: 311–314, 1985.
   PubMedGoogle Scholar
• Axelrod L, Halter JB, Cooper DS, Aoki TT, Roussel AM, Bagshaw SL: Hormonal levels and fuel flow in patients with weight loss and lung cancer. Evidence for excessive metabolic expenditure and for an adaptive response mediated by a reduced level of 3,5,3′-triiodothyronine. Metabolism 32: 924–937, 1983.
   PubMedGoogle Scholar
• Young VR: Energy metabolism and requirements in the cancer patient. Cancer Res 37: 2336–2347, 1977.
   PubMed Web of Science ®Google Scholar
• Brennan MF: Total parenteral nutrition in the cancer patient. N Engl J Med 305: 375–382, 1981.
   PubMed Web of Science ®Google Scholar
• Shaw JHF, Humberstone DM, Wolfe RR: Energy and protein metabolism in sarcoma patients. Ann Surg 207: 283–289, 1988.
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Bulcavage L, Grosvenor M, Oktay E, Block JB, Chlebowski J, Ali I, Elashoff R: Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. J Clin Oncol 8 (1):9–15, 1990.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Heber D, Byerley LO, Steiner BS, Rajfer J, Swerdloff RS: Nutritional and metabolic effects of gonado-tropin-releasing hormone agonist treatment for prostate cancer. Metabolism 39 (12):1–6, 1990.
   Google Scholar
• DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass Jr HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69: 491–497, 1980.
   PubMed Web of Science ®Google Scholar
• Chlebowski RT, Heber D, Block JB: Serial assessment of glucose metabolism in patients with cancer cachexia. Clin Res 30 (1):69A, 1982.
   Google Scholar
• Kokal WA, McCulloch A, Wright PD, Johnston IDA: Glucose turnover and recycling in colorectal carcinoma. Ann Surg 198: 601–604, 1983.
   PubMed Web of Science ®Google Scholar
• Cori CF, Cori GT: The carbohydrate metabolism of tumors. II. Changes in the sugar, lactic acid, and CO2 combining power of blood passing through a tumor. J Biol Chem 66: 397–405, 1925.
   Google Scholar
• Holyrode CP, Axelrod RS, Skutches CL, Haff AC, Paul P, Reichard GA: Lactate metabolism in patients with metastatic colorectal cancer. Cancer Res 39: 4900–4904, 1979.
   PubMedGoogle Scholar
• Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K: Metabolic balance across the leg in weight-losing cancer patients compared to depleted patients without cancer. Cancer Res 42: 4293–4299, 1982.
   PubMedGoogle Scholar
• Benn JJ, Ria R, Sonksen PH: Increased glucose carbon recycling in severely insulin deficient type I diabetic subjects. Diabetologia 33: 158–162, 1990.
   PubMedGoogle Scholar
• Albert JD, Legaspi A, Horowitz GD, Tracey KJ, Brennan MF, Lowry SF: Peripheral tissue metabolism in man with varied disease states and similar weight loss. J Surg Res 40: 374–381, 1986.
   PubMedGoogle Scholar
• Bjorkman O, Eriksson LS, Nyberg B, Wahren J: Gut exchange of glucose and lactate in basal state and after oral glucose ingestion in postoperative patients. Diabetes 39: 747–751, 1990.
   PubMedGoogle Scholar
• Clark CM, Goodlad GAJ: Depletion of proteins of phasic and tonic muscles in tumor-bearing rats. Eur J Cancer 7: 3–9, 1971.
   PubMed Web of Science ®Google Scholar
• Humberstone DA, Shaw JHF: Metabolism in hematologic malignancy. Cancer 62: 1619–1624, 1988.
   PubMed Web of Science ®Google Scholar
• Kallinowski F, Schlenger KH, Runkel S, Klees M, Stohrer M, Okunief FP, Vaupel P: Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenography Cancer Res 49: 3759–3764, 1989.
   PubMed Web of Science ®Google Scholar
• Lehninger AL: Organ interrelationships in the metabolism of mammals. In: “Biochemistry.” New York: Worth Publishers, pp 829–852, 1975.
   Google Scholar
• Russell DMR, Shike M, Marliss EB, Destky AS, Shephard FA, Feld R, Evans WK, Jeekeebhoy KN: Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer. Cancer Res 4406–1711, 1984.
   Google Scholar
• Nolop KB, Rhodes CG, Brudin LH, Beaney RP, Krausz T, Jones T, Hughes JMB: Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60: 2682–2689, 1987.
   PubMed Web of Science ®Google Scholar
• Su TS, Tsai TF, Chi CW, Han SH, Chou CK: Elevation of facilitated tolerance transporter messenger RNA in human hepatocellular carcinoma. Hepatology 11: 118–122, 1990.
   PubMed Web of Science ®Google Scholar
• Krimker VM, Goldobenko GV, Ozhiqanov YL, Aitakova IT, Dyuskaliev ZD: The use of artificial hyperglycemia in the radiotherapy of patients with rectal cancer. Vopr Onkol 32 (10):40–46, 1986.
   PubMedGoogle Scholar
• Norton JA, Gorschboth CM, Wesley RA, Burt ME, Brennan MF: Fasting plasma amino acid levels in cancer patients. Cancer 56: 1181–1186, 1985.
   PubMed Web of Science ®Google Scholar
• Bennegard K, Lindmark L, Eden E, Svaninger G, Lundholm K: Flux of amino acids across the leg in weight-losing cancer patients. Cancer Res 44: 386–393, 1984.
   PubMed Web of Science ®Google Scholar
• Felig P, Wahren J, Sherwin R, Palaiologos G: Amino acid and protein metabolism in diabetes mellitus. Arch Intern Med 137: 507–513, 1977.
   PubMedGoogle Scholar
• Waterhouse C, Jeanpretre N, Keilson J. Gluconeogenesis from alanine in patients with progressive malignant disease. Cancer Res 39: 1968–1972, 1979.
   PubMed Web of Science ®Google Scholar
• Burt ME, Gorschboth CM, Brennan MF: A controlled prospective randomized trial evaluating metabolic effects of enteral and parenteral nutrition in the cancer patient. Cancer 49: 1092–1105, 1982.
   PubMed Web of Science ®Google Scholar
• Tayek JA, Heber D, Chlebowski RT: Effect of hydrazine sulphate on whole-body protein breakdown measured by 14C-lysine metabolism in lung cancer patients. Lancet 2: 241–244, 1987.
   PubMed Web of Science ®Google Scholar
• Eden E, Ekman L, Bennegard K, Lindmark L, Lundholm K: Whole-body tyrosine flux in relation to energy expenditure in weight-losing cancer patients. Metabolism 33: 1020–1027, 1984.
   PubMedGoogle Scholar
• Shulman GI, Rothman DL, Jue T, Stein P, DeFronzo RA, Shulman RG: Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med 322: 223–228, 1990.
   PubMed Web of Science ®Google Scholar
• Bennegard K, Lundgren F, Lundhold K: Mechanism of insulin resistance in cancer associated malnutrition. Clin Physiol 6: 539–547, 1986.
   PubMedGoogle Scholar
• Copeland GP, Leinster SJ, Davis JC, Hipkin JL: Insulin resistance in patients with colorectal cancer. Br J Surg 74: 1031–1035, 1987.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tobin JD, Andres R: Glucose clamp techniques: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–E223, 1979.
   PubMed Web of Science ®Google Scholar
• Schein PS, Kisner D, Haller D, Blecher M, Hamosh M: Cachexia of malignancy: potential role of insulin nutritional management. Cancer 43: 2070–2076, 1979.
   PubMed Web of Science ®Google Scholar
• Zeiderman MR, King RF, Young GA, McMahon MJ: Metabolic changes in human liver associated with pre-operative intravenous nutrition. Clin Sci 77: 343–349, 1989.
   Google Scholar
• Jallut D, Golay A, Munger R, Frascarolo P, Schutz Y, Jequier E, Felber JP: Impaired glucose tolerance and diabetes in obesity: a 6-year follow up study of glucose metabolism. Metabolism 39: 1068–1075, 1990.
   PubMed Web of Science ®Google Scholar
• DeFronzo RA: The triumvirate: B cell, muscle, liver. Diabetes 37: 667–687, 1987.
   Google Scholar
• Emerman JT, Leahy M, Gout PW, Bruchovsky N: Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17: 421–424, 1985.
   PubMedGoogle Scholar
• Pavelic K, Pekic B, Gravilovac J, Bratic-Mikes V, Boranic M: Hormonal changes in patients with hematological malignancies. Biomedicine 35: 181–184, 1981.
   PubMedGoogle Scholar
• Vassilopoulou-Sellin R, Wallis CJ, Samaan NA: Hormonal evaluation in patients with osteosarcoma. J Surg Oncol 28: 209–213, 1985.
   PubMedGoogle Scholar
• Andrews GS: Growth hormone and malignancy. J Clin Pathol 36: 935–937, 1983.
   PubMedGoogle Scholar
• Feldman JM, Plonk JW, Bivens CH, Lebovitz HE, Handwerger S: Growth hormone and prolactin secretion in the carcinoid syndrome. Am J Med Sci 269: 333–347, 1975.
   PubMedGoogle Scholar
• Benjamin F, Casper DJ, Sherman L, Kolodny HD: Growth hormone secretion in patients with endometrial carcinoma. N Engl J Med 281: 1448–1452, 1969.
   PubMedGoogle Scholar
• Benjamin F: Growth hormone response to insulin hypoglycemia in endometrial carcinoma. Obstet Gynecol 43: 257- 261, 1974.
   PubMedGoogle Scholar
• Karlander S, Vranic M, Efendic S: Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance. Diabetologia 29: 778–783, 1986.
   PubMed Web of Science ®Google Scholar
• Dahms WT, Owens RP, Kalhan SC, Kerr DS, Danish RK: Urea synthesis, nitrogen balance and glucose turnover in growth-hormone deficient children before and after growth hormone administration. Metabolism 38: 197–203, 1989.
   PubMedGoogle Scholar
• Bougneres PF, Artavia-Loria E, Ferre P, Chaussain JL, Job JC: Effects of hypopituitarism and growth hormone replacement therapy of the production and utilization of glucose in childhood. J Clin Endocrinol Metab 61: 1152–1155, 1985.
   PubMedGoogle Scholar
• Asplin CM, Faria ACS, Carlsen EC, Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS: Alterations in the pulsatile mode of growth hormone release in men and women with IDDM. J Clin Endocrinol Metab 69: 239–245, 1989.
   PubMed Web of Science ®Google Scholar
• Evans WS, Faria ACS, Christiansen E, Ho KY, Weiss J, Rogol AD, Johnson ML, Blizzard RM, Veldhuis JD, Thorner MO: Impact of intensive venous sampling on characterization of pulsatile growth hormone release. Am J Physiol 252: E549–E556, 1987.
   Google Scholar
• Moller N, Jorgensen JOL, Schmitz O, Moller J, Christiansen J, Alberti KG, Orskov H: Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 258: E86–E91, 1990.
   PubMed Web of Science ®Google Scholar
• Moller N, Butler PC, Antsiferov MA, Alberti KGMM: Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man. Diabetologia 32: 105–110, 1989.
   PubMedGoogle Scholar
• Orskov L, Schmitz O, Jorgensen JOL, Arnfred J, Abildgaard N, Christiansen JS, Alberti KG, Orskov H: Influence of growth hormone on glucose induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique. J Clin Endocrinol Metab 68: 276–282, 1989.
   PubMedGoogle Scholar
• Tan K, Baxter RC: Serum insulin-like growth factor I level in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 63: 651–655, 1986.
   PubMedGoogle Scholar
• Perriello G, Feo PD, Torlone E, Fanelli C, Santuesanio F, Brunetti P, Bolli GB: Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type I diabetes mellitus by decreasing hepatic sensitivity to insulin in the absence of insulin waning. Diabetologia 33: 52–59, 1990.
   PubMedGoogle Scholar
• Becker DJ: The endocrine responses to protein calorie malnutrition. Ann Rev Nutr 3: 187–212, 1983.
   PubMed Web of Science ®Google Scholar
• Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS: Nutrition and somatomedin. Am J Med 78: 228–234, 1985.
   PubMed Web of Science ®Google Scholar
• Phillips LS, Unterman: Somatomedin activity in disorders of nutrition and metabolism. Clin Endocrinol Metab 13: 145–189, 1984.
   PubMedGoogle Scholar
• Bratusch-Marrian PR, Smith D, DeFronzo RA: The effect of growth hormone on glucose metabolism and insulin secretion in man. J Clin Endocrinol Metab 55: 973–982, 1982.
   PubMedGoogle Scholar
• Werk EE, Sholiton LJ, Mamell RT: Further studies of adrenocortical function in patients with carcinoma of the lung. Am J Med 34: 192–195, 1963.
   PubMed Web of Science ®Google Scholar
• Werk EE, MacGee J, Sholiton LJ: Altered Cortisol metabolism in advanced cancer and other terminal illnesses. Metabolism 13: 1425–1438, 1964.
   PubMedGoogle Scholar
• Feldman JM, Blalock JA: Urinary free Cortisol excretion in patients with metastatic cancer. Am J Med Sci 278: 149–152, 1979.
   PubMedGoogle Scholar
• Drott C, Svaninger G, Lundholm K: Increased urinary excretion of Cortisol and catecholamines in malnourished cancer patients. Ann Surg 208: 645–650, 1988.
   PubMedGoogle Scholar
• Rose DP, Fahl WE, Liskowski L: The urinary exretion of corticosteroid sulfates by cancer patients. Cancer 36: 2060–2063, 1975.
   PubMedGoogle Scholar
• Eden E, Edstrom S, Bennegard K, Schersten T, Lundholm K: Glucose flux in relation to energy expenditure in malnourished patients with and without cancer during periods of fasting and feeding. Cancer Res 44: 1718–1724, 1984.
   PubMed Web of Science ®Google Scholar
• Muller MJ, Acheson KJ, Jequier E, Burger AG: Effect of thyroid hormones on oxidative and nonoxidative glucose metabolism in humans. Am J Physiol 255: E146–E152, 1988.
   Google Scholar
• Shulman GI, Ladenson PW, Wolfe MH, Ridgway C, Wolfe RR: Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man. J Clin Invest 76: 757–764, 1985.
   PubMedGoogle Scholar
• Heber D, Byerley LO, Chi J, Grosvenor M, Bergman RN, Coleman M, Chlebowski RT: Pathophysiology of malnutrition in the adult cancer patient. Cancer 58: 1867–1873, 1986.
   PubMed Web of Science ®Google Scholar
• Nixon DW, Moffitt S, Lawson DH: Total parenteral nutrition as an adjunct to chemotherapy of metastatic colorectal cancer. Cancer Treat Rep 65: 121–128, 1981.
   PubMedGoogle Scholar
• Copeland EM: Intravenous hyperalimentation and chemotherapy: an update. JPEN 6: 236–239, 1982.
   PubMedGoogle Scholar
• Shike M, Russel DM, Detsky AS: Changes in body composition in patients with small cell lung cancer. Ann Intern Med 101: 303–304, 1984.
   PubMed Web of Science ®Google Scholar
• Reichard GA, Moury NF, Hochella NJ, Patterson AL, Wein-House S: Quantitative estimation of the Cori cycle in the human. J Biol Chem 238: 495–501, 1963.
   Web of Science ®Google Scholar
• Waterhouse C, Kemperman JH: Carbohydrate metabolism in subjects with cancer. Cancer Res 31: 1273–1278, 1971.
   PubMed Web of Science ®Google Scholar
• Lindmark L, Eden E, Terrnell M, Bennegard K, Svaninger G, Lundholm K: Thermic effect and substrate oxidation in response to intravenous nutrition in cancer patients who lose weight. Ann Surg 204: 628–636, 1986.
   PubMedGoogle Scholar
• Burt ME, Aoki TT, Gorschboth CM, Brennan MF: Peripheral tissue metabolism in cancer-bearing man. Ann Surg 198: 685–691, 1983.
   PubMed Web of Science ®Google Scholar
• Copeland GP, Al-Sumidaie AM, Leinster SJ, Davis JC, Hipkin LH: Glucose metabolism in patients with gastrointestinal malignancy but without excessive weight loss. Eur J Surg Oncol 13: 11–16, 1987.
   PubMedGoogle Scholar
• Long CL, Merrick H, Grecos G, Blakemore WS, Geiger J: Glucose metabolism and colorectal cancer. Metabolism 39: 494–501, 1990.
   PubMedGoogle Scholar
• Norton JA, Stein TP, Brennan MF: Whole body protein turnover studies in normal humans and malnourished patients with and without cancer. Surg Forum 31: 94–96, 1980.
   Google Scholar
• Jeevanadam M, Horowitz GD, Lowry SF, Brennan MF: Cancer cachexia and protein metabolism. Lancet 1: 1423–1426, 1984.
   PubMedGoogle Scholar
• Welle S, Nair KS: Relationship of resting metabolic rate to body composition and protein turnover. Am J Physiol 258.E990-E998, 1990.
   Google Scholar
• Richtsmeier WJ, Dauchy R, Lauer LA. In vivo nutrient uptake by head and neck cancers. Cancer Res 47: 5230–5233, 1987.
   PubMed Web of Science ®Google Scholar
• Hansell DT, Davies JWL, Burns HJG, Shenkin A: The oxidation of body fuel stores in cancer patients. Ann Surg 204: 637–642, 1986.
   PubMedGoogle Scholar
• Cersosimo E, Pisters PWT, Pesola G, Rogatko A, Vydelingun NA, Bajorunas D, Brennan MF: The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer chacexia. Surgery 109: 459–467, 1991.
   PubMed Web of Science ®Google Scholar
• Byerley LO, Heber D, Bergman RN, Dubria M, Chi J: Insulin action and metabolism in patients with head and neck cancer. Cancer 67: 2900–2906, 1991.
   PubMed Web of Science ®Google Scholar
• Miyoshi S, Nakahara K, Monden Y, Kawashima Y: Effect of lung resection on blood lactate threshold in lung cancer patients. Eur J Appl Physiol 57: 388–393, 1988.
   Google Scholar
• Rochester DF, Wichern WA, Fritts HW, Caldwell PRB, Lewis ML, Guintini C, Garfield JW: Arteriovenous differences of lactate and pyruvate across healthy and diseased human lung. Am Rev Respir Dis 107: 442–448, 1973.
   PubMed Web of Science ®Google Scholar
• Nowak R, Neumayer E: Das Lactat-Pyruvat-Verhaltnis im Blut bei Patienten mit einex Larynxcarcinom. Arch Klin Exp Ohren Nasen-und Kehlkopfheilk 189: 360–364, 1967.
   PubMedGoogle Scholar
• Jurga E, Klvana M, Matula P, Wagnerova M: Importance of serum hexokinase, aldolase, and lactate dehydrogenase activities, and the lactate/pyruvate quotient in the diagnosis of malignant tumors. Neoplasma 25: 95–106, 1978.
   PubMedGoogle Scholar
• Shaw JHF, Humberstone DA, Holdaway C: Weight loss in patients with head and neck cancer: malnutrition or tumor effect. Aust NZ J Surg 58: 505–509, 1988.
   PubMedGoogle Scholar
• Shaw JHF, Humberstone DA, Douglas RG, Koea J: Leucine kinetics in patients with benign disease, non-weight-losing cancer, and cancer cachexia: studies at the whole-body and tissue level and the response to nutritional support. Surgery 109: 37–50, 1991.
   PubMedGoogle Scholar
• Pisters PWT, Cersosimo E, Rogatko A, Brennan MF: Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin. Surgery 111: 301–310, 1992.
   PubMed Web of Science ®Google Scholar